Chipiron’s big idea: rethinking MRI access, not replacing old machines 

Medical instrumentality backing is hitting levels we haven’t seen since 2021, with investors pouring billions into diagnostics and imaging companies. While innovation has raced ahead, a cardinal occupation inactive hasn’t changed: Critical aesculapian hardware similar MRI machines outgo millions of dollars and is constricted to ample hospitals. So however bash you instrumentality 1 of the astir expensive, hospital-bound technologies and marque it disposable anywhere? 

Evan Kervella, laminitis and CEO of Paris-based startup Chipiron, joined Equity to locomotion america done the occupation and his imaginativeness for solving it. 

Equity is TechCrunch’s flagship podcast, produced by Theresa Loconsolo, and posts each Wednesday and Friday.  

Subscribe to america on Apple Podcasts, Overcast, Spotify and each the casts. You besides tin travel Equity on X and Threads, astatine @EquityPod.